EN
登录

费城儿童医院和Sidra Medicine将在卡塔尔建立有史以来第一个儿童骨髓移植项目

Children's Hospital of Philadelphia and Sidra Medicine to Establish First-Ever Pediatric Bone Marrow Transplant Program in Qatar

BioSpace 等信源发布 2024-05-14 20:51

可切换为仅中文


PHILADELPHIA, May 14, 2024 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) announced it has entered into a Memorandum of Understanding (MOU) with Sidra Medicine, a specialty healthcare organization for women, children and young people in Qatar. The MOU, signed by Dr. Iyabo Tinubu-Karch, CEO of Sidra Medicine, and Madeline Bell, President and CEO of Children's Hospital of Philadelphia will establish a collaboration between CHOP and Sidra Medicine in Sidra Medicine's efforts to create the first-ever pediatric bone marrow transplant (BMT) program in Qatar..

费城,2024年5月14日,费城儿童医院(CHOP)宣布,已与卡塔尔妇女、儿童和年轻人专业医疗保健组织Sidra Medicine签订谅解备忘录(MOU)。该谅解备忘录由Sidra Medicine首席执行官Iyabo Tinubu Karch博士和费城儿童医院院长兼首席执行官Madeline Bell签署,将在CHOP和Sidra Medicine之间建立合作关系,以帮助Sidra Medicine在卡塔尔创建有史以来第一个儿科骨髓移植(BMT)项目。。

The MOU signing ceremony was held at CHOP and attended by H.E. Mohammed Bin Sultan Alkuwari, Consul General of the State of Qatar in New York, as well as Dr. Ahmed Al Hammadi, Acting Chief Medical Officer of Sidra Medicine, and Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine. The main objective of the MOU is to establish a working relationship between CHOP's Cellular Therapy and Transplant Section (CTTS) and Sidra Medicine.

谅解备忘录签署仪式在CHOP举行,卡塔尔国驻纽约总领事穆罕默德·本·苏丹·阿尔库瓦里(H.E.Mohammed Bin Sultan Alkuwari)、西德拉医学代理首席医学官艾哈迈德·哈马迪(Ahmed Al-Hammadi)博士和西德拉医学首席研究官哈立德·法赫罗(Khalid Fakhro)教授出席了仪式。谅解备忘录的主要目的是在CHOP的细胞治疗和移植科(CTTS)与Sidra Medicine之间建立工作关系。

CHOP's CTTS will offer guidance as Sidra Medicine pursues an in-country BMT program, provide a robust education plan for its BMT clinical staff and assess readiness to start treating pediatric patients..

随着Sidra Medicine在国内推行BMT计划,CHOP的CTT将提供指导,为其BMT临床员工提供强大的教育计划,并评估开始治疗儿科患者的准备情况。。

CHOP's Blood and Marrow Transplant program is part of CTTS and serves the needs of children who require a blood or marrow transplant to replace stem cells to treat their illness. Transplant is a treatment for a variety of diseases including certain types of pediatric cancer, disorders of the blood and immune system as well as a variety of other rare disorders and syndromes.

CHOP的血液和骨髓移植计划是CTTS的一部分,为需要血液或骨髓移植来替代干细胞治疗疾病的儿童提供服务。移植是一种治疗多种疾病的方法,包括某些类型的儿科癌症,血液和免疫系统疾病以及各种其他罕见疾病和综合征。

CHOP's BMT program has been serving the needs of pediatric patients since 1976 and is recognized for its quality, service, innovative approaches and excellent patient outcomes. The program has one of the highest volumes of pediatric blood and marrow transplant-eligible patients among BMT providers in the United States..

自1976年以来,CHOP的BMT计划一直在服务儿科患者的需求,并因其质量,服务,创新方法和出色的患者结果而受到认可。该项目是美国BMT提供者中儿科血液和骨髓移植合格患者数量最多的项目之一。。

'CHOP is dedicated to improving health outcomes for children across the world,' said Ruth Frey, Vice President of Global Strategy and Business Development at CHOP. 'We are thrilled about this collaboration and the opportunity to offer CHOP's BMT expertise to support Sidra Medicine's launch of the first-ever pediatric BMT program in Qatar.'.

CHOP全球战略和业务发展副总裁露丝·弗雷(RuthFrey)说,CHOP致力于改善全世界儿童的健康状况我们对这次合作感到兴奋,并有机会提供CHOP的BMT专业知识,以支持Sidra Medicine在卡塔尔推出有史以来第一个儿科BMT项目。”。

Sidra Medicine is the only hospital in Qatar to provide pediatric hematology and oncology care for children and young people with cancer and blood disorders. The hospital sees approximately 70 to 100 cases of childhood cancer cases every year, with leukemia, central nervous system tumours and lymphoma amongst the most common..

Sidra Medicine是卡塔尔唯一一家为患有癌症和血液疾病的儿童和年轻人提供儿科血液学和肿瘤学护理的医院。该医院每年约有70至100例儿童癌症病例,其中最常见的是白血病,中枢神经系统肿瘤和淋巴瘤。。

Dr. Ahmed Al Hammadi, Acting Chief Medical Officer and Executive Chair of Pediatrics at Sidra Medicine, said, 'As a leader in specialist pediatric care in Qatar and the region, Sidra Medicine is proudly working alongside the top international health and research organizations to enhance our expertise in precision medicine.

Sidra Medicine代理首席医疗官兼儿科执行主席Ahmed Al-Hammadi博士说,“作为卡塔尔和该地区儿科专科护理的领导者,Sidra Medicine自豪地与顶级国际卫生和研究组织合作,以增强我们在精准医学方面的专业知识。

It is truly a milestone to launch Qatar's first pediatric BMT program and we are delighted to partner with a world-class institution like CHOP to provide our patients with the most advanced and effective treatment options. Taking our renowned multidisciplinary approach, different pediatric specialties will coordinate and work as a single unit to offer holistic and excellent care to our patients.'.

启动卡塔尔第一个儿科BMT项目确实是一个里程碑,我们很高兴与CHOP这样的世界级机构合作,为我们的患者提供最先进和有效的治疗选择。采用我们著名的多学科方法,不同的儿科专业将作为一个单一的单位进行协调和工作,为我们的患者提供全面和优质的护理。”。

The BMT program at Sidra Medicine will treat patients with various blood diseases and cancers including sickle cell disease, thalassemia, leukemia, lymphoma and solid tumors. In addition, the program will treat pediatric patients with primary immune deficiencies, metabolic diseases, and certain genetic and autoimmune disorders..

Sidra Medicine的BMT项目将治疗各种血液疾病和癌症患者,包括镰状细胞病、地中海贫血、白血病、淋巴瘤和实体瘤。此外,该计划将治疗患有原发性免疫缺陷,代谢性疾病以及某些遗传和自身免疫性疾病的儿科患者。。

In parallel to this work, CHOP and Sidra Medicine will also explore potential collaborations on clinical research in cell and gene therapies. CHOP has been a global leader in cell and gene therapies in which CHOP's CTTS has played a key role in the clinical trials, including all FDA approved therapies currently available.

与这项工作同时,CHOP和Sidra Medicine还将探索细胞和基因疗法临床研究的潜在合作。CHOP一直是细胞和基因疗法的全球领导者,CHOP的CTT在临床试验中发挥了关键作用,包括目前所有FDA批准的疗法。

These therapies involve treatment for conditions such as sickle cell disease, beta thalassemia and adrenoleukodystrophy..

这些疗法包括治疗镰状细胞病、β地中海贫血和肾上腺白质营养不良等疾病。。

About Children's Hospital of Philadelphia

关于费城儿童医院

A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, the hospital has fostered many discoveries that have benefited children worldwide.

费城儿童医院(Children's Hospital of Philadelphia)是一家非营利性慈善组织,成立于1855年,是美国第一家儿科医院。通过长期致力于提供卓越的患者护理,培训新一代儿科医疗保健专业人员以及开创性的重大研究计划,该医院促进了许多有益于全世界儿童的发现。

Its pediatric research program is among the largest in the country. The institution has a well-established history of providing advanced pediatric care close to home through its CHOP Care Network, which includes more than 50 primary care practices, specialty care and surgical centers, urgent care centers, and community hospital alliances throughout Pennsylvania and New Jersey, as well as the Middleman Family Pavilion and its dedicated pediatric emergency department in King of Prussia.

它的儿科研究项目是国内规模最大的项目之一。该机构拥有通过其CHOP护理网络提供离家近的先进儿科护理的悠久历史,该网络包括宾夕法尼亚州和新泽西州的50多家初级保健机构、专科护理和外科中心、紧急护理中心和社区医院联盟,以及普鲁士国王的Middleman Family Pavilion及其专门的儿科急诊室。

In addition, its unique family-centered care and public service programs have brought Children's Hospital of Philadelphia recognition as a leading advocate for children and adolescents. For more information, visit https://www.chop.edu..

此外,其独特的以家庭为中心的护理和公共服务计划使费城儿童医院成为儿童和青少年的主要倡导者。有关更多信息,请访问https://www.chop.edu..

About Sidra Medicine

关于Sidra Medicine

From the heart of Qatar, Sidra Medicine, a private, not-for-profit organization established by the Qatar Foundation for Education, Science, and Community Development, is a leading academic healthcare and research institution for women, children and young people. The hospital is committed to delivering exceptional patient and family-focused care, conducting innovative biomedical and clinical research, and providing a personalized journey of care and cure and precision medicine specifically for rare diseases.

卡塔尔教育、科学和社区发展基金会(Qatar Foundation for Education,Science and Community Development)成立的私人非营利组织Sidra Medicine位于卡塔尔的心脏地带,是一家领先的针对妇女、儿童和年轻人的学术保健和研究机构。该医院致力于提供卓越的以患者和家庭为中心的护理,进行创新的生物医学和临床研究,并为罕见疾病提供个性化的护理和治疗以及精准医学之旅。

To access our specialized healthcare or international patient services, including pediatric care, women's health, and rare disease treatment or to book a consultation at one of our private clinics, please call +974 40033333 or visit our website at http://www.sidra.org..

要访问我们的专业医疗保健或国际患者服务,包括儿科护理、妇女健康和罕见病治疗,或在我们的私人诊所预约咨询,请致电+974 40033333或访问我们的网站http://www.sidra.org..

Contact:

联系人:

Jennifer Lee

珍妮弗·李

Children's Hospital of Philadelphia

费城儿童医院

LEEJ41@chop.edu

LEEJ41@chop.edu

610-800-6592

610-800-6592

View original content to download multimedia:https://www.prnewswire.com/news-releases/childrens-hospital-of-philadelphia-and-sidra-medicine-to-establish-first-ever-pediatric-bone-marrow-transplant-program-in-qatar-302144284.html

查看原始内容以下载多媒体:https://www.prnewswire.com/news-releases/childrens-hospital-of-philadelphia-and-sidra-medicine-to-establish-first-ever-pediatric-bone-marrow-transplant-program-in-qatar-302144284.html

SOURCE Children's Hospital of Philadelphia

费城SOURCE儿童医院